184 related articles for article (PubMed ID: 25456871)
1. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).
Ashburner JM; Go AS; Reynolds K; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
Am J Cardiol; 2015 Jan; 115(1):40-6. PubMed ID: 25456871
[TBL] [Abstract][Full Text] [Related]
2. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
Fang MC; Go AS; Hylek EM; Chang Y; Henault LE; Jensvold NG; Singer DE
J Am Geriatr Soc; 2006 Aug; 54(8):1231-6. PubMed ID: 16913990
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
6. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.
Singer DE; Chang Y; Borowsky LH; Fang MC; Pomernacki NK; Udaltsova N; Reynolds K; Go AS
J Am Heart Assoc; 2013 Jun; 2(3):e000250. PubMed ID: 23782923
[TBL] [Abstract][Full Text] [Related]
7. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
8. Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
Fang MC; Go AS; Chang Y; Hylek EM; Henault LE; Jensvold NG; Singer DE
Am J Med; 2007 Aug; 120(8):700-5. PubMed ID: 17679129
[TBL] [Abstract][Full Text] [Related]
9. Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.
Baumgartner C; Fan D; Fang MC; Singer DE; Witt DM; Schmelzer JR; Williams MS; Gurwitz JH; Sung SH; Go AS
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29656278
[TBL] [Abstract][Full Text] [Related]
10. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
11. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.
Fang MC; Singer DE; Chang Y; Hylek EM; Henault LE; Jensvold NG; Go AS
Circulation; 2005 Sep; 112(12):1687-91. PubMed ID: 16157766
[TBL] [Abstract][Full Text] [Related]
14. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.
Ashburner JM; Go AS; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
J Am Geriatr Soc; 2017 Jan; 65(1):35-41. PubMed ID: 27861698
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
16. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
Vestergaard AS; Skjøth F; Lip GY; Larsen TB
Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
[TBL] [Abstract][Full Text] [Related]
17. Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated?
Bratland B; Hornnes MB
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):175-9. PubMed ID: 24477151
[TBL] [Abstract][Full Text] [Related]
18. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.
Björck S; Palaszewski B; Friberg L; Bergfeldt L
Stroke; 2013 Nov; 44(11):3103-8. PubMed ID: 23982711
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
Schauer DP; Moomaw CJ; Wess M; Webb T; Eckman MH
J Gen Intern Med; 2005 Dec; 20(12):1114-9. PubMed ID: 16423100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
